Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles D Smith

Showing results (161-170 of 200) with videos related to

Pageof 20
Sort By:
Cancer Biology & Therapy|July 5, 2011
Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agentsWenge Wang, Jean-Nicolas Gallant, Sharyn I Katz, et al.
Neurology|September 26, 2014
Self-reported memory complaints: implications from a longitudinal cohort with autopsiesRichard J Kryscio, Erin L Abner, Gregory E Cooper, et al.
Blood|December 8, 2009
A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphomaYing-Wei Lin, Zanna M Beharry, Elizabeth G Hill, et al.
Journal of Alzheimer'S Disease : JAD|April 8, 2011
"End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction?Erin L Abner, Richard J Kryscio, Frederick A Schmitt, et al.
Molecular Cancer Therapeutics|October 22, 2013
Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphomaZhiqiang Qin, Lu Dai, Jimena Trillo-Tinoco, et al.
Brain Pathology (Zurich, Switzerland)|November 22, 2008
Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly personsPeter T Nelson, Erin L Abner, Frederick A Schmitt, et al.
Journal of Alzheimer'S Disease : JAD|April 19, 2011
Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognitionKathryn P Riley, Gregory A Jicha, Daron Davis, et al.
Neuroimage. Clinical|December 13, 2016
Development, validation and application of a new fornix template for studies of aging and preclinical Alzheimer's diseaseChristopher A Brown, Nathan F Johnson, Amelia J Anderson-Mooney, et al.
Journal of Alzheimer'S Disease : JAD|March 20, 2013
Adjusting for mortality when identifying risk factors for transitions to mild cognitive impairment and dementiaRichard J Kryscio, Erin L Abner, Yushun Lin, et al.
Neurobiology of Aging|April 22, 2011
Preclinical AD Workgroup staging: pathological correlates and potential challengesGregory A Jicha, Erin L Abner, Frederick A Schmitt, et al.
Pageof 20

Showing results (161-170 of 200) with videos related to

Sort By:
Pageof 20
Cancer Biology & Therapy|July 5, 2011
Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agentsWenge Wang, Jean-Nicolas Gallant, Sharyn I Katz, et al.
Neurology|September 26, 2014
Self-reported memory complaints: implications from a longitudinal cohort with autopsiesRichard J Kryscio, Erin L Abner, Gregory E Cooper, et al.
Blood|December 8, 2009
A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphomaYing-Wei Lin, Zanna M Beharry, Elizabeth G Hill, et al.
Journal of Alzheimer'S Disease : JAD|April 8, 2011
"End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction?Erin L Abner, Richard J Kryscio, Frederick A Schmitt, et al.
Molecular Cancer Therapeutics|October 22, 2013
Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphomaZhiqiang Qin, Lu Dai, Jimena Trillo-Tinoco, et al.
Brain Pathology (Zurich, Switzerland)|November 22, 2008
Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly personsPeter T Nelson, Erin L Abner, Frederick A Schmitt, et al.
Journal of Alzheimer'S Disease : JAD|April 19, 2011
Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognitionKathryn P Riley, Gregory A Jicha, Daron Davis, et al.
Neuroimage. Clinical|December 13, 2016
Development, validation and application of a new fornix template for studies of aging and preclinical Alzheimer's diseaseChristopher A Brown, Nathan F Johnson, Amelia J Anderson-Mooney, et al.
Journal of Alzheimer'S Disease : JAD|March 20, 2013
Adjusting for mortality when identifying risk factors for transitions to mild cognitive impairment and dementiaRichard J Kryscio, Erin L Abner, Yushun Lin, et al.
Neurobiology of Aging|April 22, 2011
Preclinical AD Workgroup staging: pathological correlates and potential challengesGregory A Jicha, Erin L Abner, Frederick A Schmitt, et al.
Pageof 20